CN1948328B - Methyl amine abamectin acylate and its preparation method and application - Google Patents
Methyl amine abamectin acylate and its preparation method and application Download PDFInfo
- Publication number
- CN1948328B CN1948328B CN200610123017A CN200610123017A CN1948328B CN 1948328 B CN1948328 B CN 1948328B CN 200610123017 A CN200610123017 A CN 200610123017A CN 200610123017 A CN200610123017 A CN 200610123017A CN 1948328 B CN1948328 B CN 1948328B
- Authority
- CN
- China
- Prior art keywords
- abamectin
- methylamino
- organic acid
- acid
- emamectin benzoate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 239000005660 Abamectin Substances 0.000 title claims description 93
- 229950008167 abamectin Drugs 0.000 title claims description 80
- IBSREHMXUMOFBB-JFUDTMANSA-N 5u8924t11h Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O3)C=C[C@H](C)[C@@H](C(C)C)O4)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 IBSREHMXUMOFBB-JFUDTMANSA-N 0.000 title description 57
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 title 2
- ODIGIKRIUKFKHP-UHFFFAOYSA-N (n-propan-2-yloxycarbonylanilino) acetate Chemical compound CC(C)OC(=O)N(OC(C)=O)C1=CC=CC=C1 ODIGIKRIUKFKHP-UHFFFAOYSA-N 0.000 title 1
- GCKZANITAMOIAR-XWVCPFKXSA-N dsstox_cid_14566 Chemical compound [O-]C(=O)C1=CC=CC=C1.C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H]([NH2+]C)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 GCKZANITAMOIAR-XWVCPFKXSA-N 0.000 claims abstract description 68
- -1 organic acid salt Chemical class 0.000 claims abstract description 40
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 23
- 239000000126 substance Substances 0.000 claims abstract description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 47
- 239000000243 solution Substances 0.000 claims description 15
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 11
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims description 11
- 238000003756 stirring Methods 0.000 claims description 11
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 9
- 241000243770 Bursaphelenchus Species 0.000 claims description 8
- 239000000575 pesticide Substances 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 7
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 6
- 150000007524 organic acids Chemical class 0.000 claims description 6
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 5
- 239000003517 fume Substances 0.000 claims description 5
- 230000007935 neutral effect Effects 0.000 claims description 4
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 3
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- 238000004440 column chromatography Methods 0.000 claims description 3
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 claims description 3
- 235000019253 formic acid Nutrition 0.000 claims description 3
- 238000004108 freeze drying Methods 0.000 claims description 3
- 239000001630 malic acid Substances 0.000 claims description 3
- 235000011090 malic acid Nutrition 0.000 claims description 3
- 239000011259 mixed solution Substances 0.000 claims description 3
- 235000006408 oxalic acid Nutrition 0.000 claims description 3
- 239000004334 sorbic acid Substances 0.000 claims description 3
- 235000010199 sorbic acid Nutrition 0.000 claims description 3
- 229940075582 sorbic acid Drugs 0.000 claims description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 150000005838 radical anions Chemical class 0.000 claims description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 36
- 241000607479 Yersinia pestis Species 0.000 abstract description 20
- 150000001875 compounds Chemical class 0.000 abstract description 13
- 239000003814 drug Substances 0.000 description 39
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 33
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 18
- 238000012360 testing method Methods 0.000 description 16
- 238000002347 injection Methods 0.000 description 14
- 239000007924 injection Substances 0.000 description 14
- 241001147381 Helicoverpa armigera Species 0.000 description 13
- 239000003795 chemical substances by application Substances 0.000 description 13
- 238000000034 method Methods 0.000 description 13
- 229940079593 drug Drugs 0.000 description 12
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 11
- 235000011613 Pinus brutia Nutrition 0.000 description 11
- 241000018646 Pinus brutia Species 0.000 description 11
- 241000196324 Embryophyta Species 0.000 description 10
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 230000000749 insecticidal effect Effects 0.000 description 9
- 230000009885 systemic effect Effects 0.000 description 9
- RRZXIRBKKLTSOM-XPNPUAGNSA-N avermectin B1a Chemical compound C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 RRZXIRBKKLTSOM-XPNPUAGNSA-N 0.000 description 8
- 241000244206 Nematoda Species 0.000 description 7
- 239000004530 micro-emulsion Substances 0.000 description 7
- 230000002265 prevention Effects 0.000 description 7
- 239000005894 Emamectin Substances 0.000 description 6
- 241000437063 Phyllotreta striolata Species 0.000 description 6
- 229940049920 malate Drugs 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 229940075554 sorbate Drugs 0.000 description 6
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 6
- 230000001988 toxicity Effects 0.000 description 6
- 231100000419 toxicity Toxicity 0.000 description 6
- 241000243771 Bursaphelenchus xylophilus Species 0.000 description 5
- 241000426497 Chilo suppressalis Species 0.000 description 5
- 241000500437 Plutella xylostella Species 0.000 description 5
- 229940077388 benzenesulfonate Drugs 0.000 description 5
- 238000004811 liquid chromatography Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 229940051841 polyoxyethylene ether Drugs 0.000 description 5
- 229920000056 polyoxyethylene ether Polymers 0.000 description 5
- 231100000820 toxicity test Toxicity 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 241001477931 Mythimna unipuncta Species 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- ATROHALUCMTWTB-OWBHPGMISA-N phoxim Chemical compound CCOP(=S)(OCC)O\N=C(\C#N)C1=CC=CC=C1 ATROHALUCMTWTB-OWBHPGMISA-N 0.000 description 4
- 229950001664 phoxim Drugs 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- WSWCOQWTEOXDQX-MQQKCMAXSA-M (E,E)-sorbate Chemical compound C\C=C\C=C\C([O-])=O WSWCOQWTEOXDQX-MQQKCMAXSA-M 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 241000594031 Liriomyza sativae Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000243795 Ostertagia Species 0.000 description 3
- 241000255969 Pieris brassicae Species 0.000 description 3
- 235000011609 Pinus massoniana Nutrition 0.000 description 3
- 241000018650 Pinus massoniana Species 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 229960000583 acetic acid Drugs 0.000 description 3
- 230000007547 defect Effects 0.000 description 3
- 238000007598 dipping method Methods 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 239000004816 latex Substances 0.000 description 3
- 229920000126 latex Polymers 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000002689 soil Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- KAATUXNTWXVJKI-NSHGMRRFSA-N (1R)-cis-(alphaS)-cypermethrin Chemical compound CC1(C)[C@@H](C=C(Cl)Cl)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 KAATUXNTWXVJKI-NSHGMRRFSA-N 0.000 description 2
- DMAXMXPDVWTIRV-UHFFFAOYSA-N 2-(2-phenylethyl)phenol Chemical compound OC1=CC=CC=C1CCC1=CC=CC=C1 DMAXMXPDVWTIRV-UHFFFAOYSA-N 0.000 description 2
- ZOCSXAVNDGMNBV-UHFFFAOYSA-N 5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile Chemical compound NC1=C(S(=O)C(F)(F)F)C(C#N)=NN1C1=C(Cl)C=C(C(F)(F)F)C=C1Cl ZOCSXAVNDGMNBV-UHFFFAOYSA-N 0.000 description 2
- 239000005944 Chlorpyrifos Substances 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- 239000005946 Cypermethrin Substances 0.000 description 2
- 239000005891 Cyromazine Substances 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 239000005899 Fipronil Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 2
- 241000255967 Helicoverpa zea Species 0.000 description 2
- 241000256257 Heliothis Species 0.000 description 2
- 241000256244 Heliothis virescens Species 0.000 description 2
- 241000255777 Lepidoptera Species 0.000 description 2
- 241000500441 Plutellidae Species 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 241000256247 Spodoptera exigua Species 0.000 description 2
- 241000985245 Spodoptera litura Species 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 239000000642 acaricide Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- KXRPCFINVWWFHQ-UHFFFAOYSA-N cadusafos Chemical compound CCC(C)SP(=O)(OCC)SC(C)CC KXRPCFINVWWFHQ-UHFFFAOYSA-N 0.000 description 2
- CWFOCCVIPCEQCK-UHFFFAOYSA-N chlorfenapyr Chemical compound BrC1=C(C(F)(F)F)N(COCC)C(C=2C=CC(Cl)=CC=2)=C1C#N CWFOCCVIPCEQCK-UHFFFAOYSA-N 0.000 description 2
- SBPBAQFWLVIOKP-UHFFFAOYSA-N chlorpyrifos Chemical compound CCOP(=S)(OCC)OC1=NC(Cl)=C(Cl)C=C1Cl SBPBAQFWLVIOKP-UHFFFAOYSA-N 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 229960001591 cyfluthrin Drugs 0.000 description 2
- QQODLKZGRKWIFG-QSFXBCCZSA-N cyfluthrin Chemical compound CC1(C)[C@@H](C=C(Cl)Cl)[C@H]1C(=O)O[C@@H](C#N)C1=CC=C(F)C(OC=2C=CC=CC=2)=C1 QQODLKZGRKWIFG-QSFXBCCZSA-N 0.000 description 2
- KAATUXNTWXVJKI-UHFFFAOYSA-N cypermethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OC(C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 KAATUXNTWXVJKI-UHFFFAOYSA-N 0.000 description 2
- 229960005424 cypermethrin Drugs 0.000 description 2
- LVQDKIWDGQRHTE-UHFFFAOYSA-N cyromazine Chemical compound NC1=NC(N)=NC(NC2CC2)=N1 LVQDKIWDGQRHTE-UHFFFAOYSA-N 0.000 description 2
- 229950000775 cyromazine Drugs 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 238000010410 dusting Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- ZNOLGFHPUIJIMJ-UHFFFAOYSA-N fenitrothion Chemical compound COP(=S)(OC)OC1=CC=C([N+]([O-])=O)C(C)=C1 ZNOLGFHPUIJIMJ-UHFFFAOYSA-N 0.000 description 2
- 229940013764 fipronil Drugs 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 208000006278 hypochromic anemia Diseases 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- QYMMJNLHFKGANY-UHFFFAOYSA-N profenofos Chemical compound CCCSP(=O)(OCC)OC1=CC=C(Br)C=C1Cl QYMMJNLHFKGANY-UHFFFAOYSA-N 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000001384 succinic acid Substances 0.000 description 2
- 235000011044 succinic acid Nutrition 0.000 description 2
- QSOHVSNIQHGFJU-UHFFFAOYSA-L thiosultap disodium Chemical compound [Na+].[Na+].[O-]S(=O)(=O)SCC(N(C)C)CSS([O-])(=O)=O QSOHVSNIQHGFJU-UHFFFAOYSA-L 0.000 description 2
- UUFQTNFCRMXOAE-UHFFFAOYSA-N 1-methylmethylene Chemical compound C[CH] UUFQTNFCRMXOAE-UHFFFAOYSA-N 0.000 description 1
- XKZQKPRCPNGNFR-UHFFFAOYSA-N 2-(3-hydroxyphenyl)phenol Chemical compound OC1=CC=CC(C=2C(=CC=CC=2)O)=C1 XKZQKPRCPNGNFR-UHFFFAOYSA-N 0.000 description 1
- YSUQLAYJZDEMOT-UHFFFAOYSA-N 2-(butoxymethyl)oxirane Chemical compound CCCCOCC1CO1 YSUQLAYJZDEMOT-UHFFFAOYSA-N 0.000 description 1
- GVNVAWHJIKLAGL-UHFFFAOYSA-N 2-(cyclohexen-1-yl)cyclohexan-1-one Chemical compound O=C1CCCCC1C1=CCCCC1 GVNVAWHJIKLAGL-UHFFFAOYSA-N 0.000 description 1
- AOBIOSPNXBMOAT-UHFFFAOYSA-N 2-[2-(oxiran-2-ylmethoxy)ethoxymethyl]oxirane Chemical compound C1OC1COCCOCC1CO1 AOBIOSPNXBMOAT-UHFFFAOYSA-N 0.000 description 1
- 241000238876 Acari Species 0.000 description 1
- 241000238421 Arthropoda Species 0.000 description 1
- ZFUKERYTFURFGA-UHFFFAOYSA-N Avermectin B1b Natural products O1C(C)C(O)C(OC)CC1OC1C(OC)CC(OC2C(=CCC3CC(CC4(O3)C=CC(C)C(C(C)C)O4)OC(=O)C3C=C(C)C(O)C4OCC(C34O)=CC=CC2C)C)OC1C ZFUKERYTFURFGA-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000317914 Chrysis Species 0.000 description 1
- 101150065749 Churc1 gene Proteins 0.000 description 1
- 241000143939 Colias eurytheme Species 0.000 description 1
- 241001641310 Cunea Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 239000005892 Deltamethrin Substances 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 1
- 241000357439 Epinephelus Species 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 241000189565 Frankliniella Species 0.000 description 1
- 241000927584 Frankliniella occidentalis Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241001531327 Hyphantria cunea Species 0.000 description 1
- 241000594036 Liriomyza Species 0.000 description 1
- 241000012186 Litura Species 0.000 description 1
- 241000555300 Mamestra Species 0.000 description 1
- 241000409991 Mythimna separata Species 0.000 description 1
- IGFHQQFPSIBGKE-UHFFFAOYSA-N Nonylphenol Natural products CCCCCCCCCC1=CC=C(O)C=C1 IGFHQQFPSIBGKE-UHFFFAOYSA-N 0.000 description 1
- 241000209094 Oryza Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- FQYUMYWMJTYZTK-UHFFFAOYSA-N Phenyl glycidyl ether Chemical compound C1OC1COC1=CC=CC=C1 FQYUMYWMJTYZTK-UHFFFAOYSA-N 0.000 description 1
- 241001582367 Polia Species 0.000 description 1
- 208000000474 Poliomyelitis Diseases 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 102100038239 Protein Churchill Human genes 0.000 description 1
- 244000184734 Pyrus japonica Species 0.000 description 1
- 241001327627 Separata Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 241000753145 Sitotroga cerealella Species 0.000 description 1
- 239000004283 Sodium sorbate Substances 0.000 description 1
- 241001468227 Streptomyces avermitilis Species 0.000 description 1
- 241000315804 Streptomyces avermitilis MA-4680 = NBRC 14893 Species 0.000 description 1
- 241000223230 Trichosporon Species 0.000 description 1
- 230000000895 acaricidal effect Effects 0.000 description 1
- KSZVHVUMUSIKTC-UHFFFAOYSA-N acetic acid;propan-2-one Chemical compound CC(C)=O.CC(O)=O KSZVHVUMUSIKTC-UHFFFAOYSA-N 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000004996 alkyl benzenes Chemical class 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- RRZXIRBKKLTSOM-UHFFFAOYSA-N avermectin B1a Natural products C1=CC(C)C(C(C)CC)OC11OC(CC=C(C)C(OC2OC(C)C(OC3OC(C)C(O)C(OC)C3)C(OC)C2)C(C)C=CC=C2C3(C(C(=O)O4)C=C(C)C(O)C3OC2)O)CC4C1 RRZXIRBKKLTSOM-UHFFFAOYSA-N 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 235000021329 brown rice Nutrition 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- OOCMUZJPDXYRFD-UHFFFAOYSA-L calcium;2-dodecylbenzenesulfonate Chemical compound [Ca+2].CCCCCCCCCCCCC1=CC=CC=C1S([O-])(=O)=O.CCCCCCCCCCCCC1=CC=CC=C1S([O-])(=O)=O OOCMUZJPDXYRFD-UHFFFAOYSA-L 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 229960002483 decamethrin Drugs 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- OWZREIFADZCYQD-NSHGMRRFSA-N deltamethrin Chemical compound CC1(C)[C@@H](C=C(Br)Br)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 OWZREIFADZCYQD-NSHGMRRFSA-N 0.000 description 1
- 238000001212 derivatisation Methods 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 239000004495 emulsifiable concentrate Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 231100000584 environmental toxicity Toxicity 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000002070 germicidal effect Effects 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 239000003630 growth substance Substances 0.000 description 1
- 230000002363 herbicidal effect Effects 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 238000000593 microemulsion method Methods 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000005645 nematicide Substances 0.000 description 1
- SNQQPOLDUKLAAF-UHFFFAOYSA-N nonylphenol Chemical compound CCCCCCCCCC1=CC=CC=C1O SNQQPOLDUKLAAF-UHFFFAOYSA-N 0.000 description 1
- 239000003987 organophosphate pesticide Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 238000012113 quantitative test Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000001846 repelling effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000010956 selective crystallization Methods 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- LROWVYNUWKVTCU-STWYSWDKSA-M sodium sorbate Chemical compound [Na+].C\C=C\C=C\C([O-])=O LROWVYNUWKVTCU-STWYSWDKSA-M 0.000 description 1
- 235000019250 sodium sorbate Nutrition 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 238000012385 systemic delivery Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000012384 transportation and delivery Methods 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 239000004563 wettable powder Substances 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
Landscapes
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
The present invention discloses a kind of methylaminoabamectin organic acid salt, its preparation method and application. Said invention also provides its chemical structure formula. As compared withabamectin and emamectin benzoate the ratio of its polar group in the compound can be greatly raised, and its solubility in the water also is obviously raised, so that it can greatly raise effect for controlling plant pests.
Description
Technical Field
The invention belongs to the field of pesticides, and particularly relates to methylamino abamectin organic acid salts, and a preparation method and application thereof.
Background
In 1975, researchers at northern research institute of japan separated a Streptomyces avermitilis MA-4680(NRRL8165) from soil samples from Jinggang county, and subsequently Merck, usa extracted a group of mixed natural products consisting of 8 structurally similar homologues from fermented mycelia of the Streptomyces avermitilis, and named avermectins (avermectins, AVM for short). In 1981, the company realizes the industrialization of abamectin and gradually applies to the aspects of agriculture and animal husbandry and sanitation. At the end of the 80 s, abamectin strains are introduced in China, and the research on strain separation, mutation breeding, fermentation process, extraction and refining and the like is carried out by units such as Shanghai pesticide research institute, Chinese agriculture university and the like, so that the production and use of abamectin in China are promoted. The compound has strong repelling and killing effect on nematode and arthropod parasitized in animal body, can reduce the dosage from mg/kg level to mu g/kg level, and has the features of unique action mechanism, high safety, etc. the medicine is first used as one kind of parasite resisting medicine for preventing and treating parasite in animal body. The drug is found to have good control effect on a plurality of pests and mites on crops, so that the drug is used as an insecticide and acaricide to control agricultural pests. According to Bloom reports of researchers of the U.S. Food and Drug Administration (FDA) in 1993, AVM not only is tightly combined with soil in a natural environment and is not easily washed and infiltrated, but also is rapidly degraded into an inactive compound under a light condition or under the action of soil microorganisms, and molecular fragments of the AVM are finally decomposed and utilized by plants and microorganisms as a carbon source without any residual toxicity. Abamectin is an important antibiotic and has become an efficient biological source pesticide for agriculture and veterinary use. To date, some of the deficiencies have been gradually revealed by the use of avermectins. The test proves that: it is inactive against eggs of many pests, is not systemic, and has developed resistance to certain pests. Therefore, except that the yield of the strain is improved by a biotechnology means, and the activity of the strain is improved by improving a production process and a preparation technology, the derivative modification is carried out on a parent structure to overcome certain defects of the original parent abamectin, and the application of the compound in the aspects of control range, insecticidal activity, human and animal toxicity, environmental toxicity and the like is expanded.
In 1984, Merk corporation started to perform derivatization research on the hydroxyl group on 4 '- (alpha-L-oleanolic group) alpha-L-oleanolic group of abamectin, and developed 4' -deoxy-4 abamectin B1 a/B1B. In 1989, the company develops 4 '-epi-methylamino-4' deoxyabamectin, and finds that the deoxyabamectin has strong insecticidal effect on lepidoptera pests. Later, to solve the stability problem of 4 '-epi-methylamino-4' deoxyabamectin, Merk company in 1994 started to research the stability of various organic acid salts thereof and finally screened out 4 '-epi-methylamino-4' deoxyabamectin benzoate as a development object, and the compound is the emamectin benzoate which is increasingly widely applied in agricultural pest control at present. The success of the development of emamectin benzoate greatly improves the application of abamectin in the prevention and treatment of pests such as lepidoptera pests, pine wood nematodes and the like, but because the solubility of the emamectin benzoate in water is very low, the emamectin benzoate has weak systemic delivery conductivity in plant bodies, and in addition, the emamectin benzoate has the defects of too narrow insecticidal spectrum, low activity on other important pests and the like, the application of the abamectin in the pests in agriculture and forestry is greatly restricted. Researches show that in the processing process of emamectin benzoate, after the screening range of organic acid is enlarged, certain salts obtained far exceed emamectin benzoate in the aspects of water solubility, systemic infusion conductivity in plant bodies and bioactivity, and the application range of the medicines in the prevention and treatment of plant diseases and insect pests is greatly widened.
Disclosure of Invention
The invention aims to overcome the defects of the existing emamectin benzoate in pest control and provides a methylamino abamectin organic acid salt which has good pest control effect, wide pest control range and easy degradation.
The invention also aims to provide a preparation method of the methylamino abamectin organic acid salt.
The invention further aims to provide the application of the methylamino abamectin organic acid salt in preparing the pesticide.
The invention relates to a methylamino abamectin organic acid salt, which has the structural formula as follows:
wherein:
x represents CH3Or CH2CH3
R-And represents acid radical anion of formic acid, acetic acid, acrylic acid, sorbic acid, malic acid, oxalic acid or succinic acid:
HCOO- CH3COO-
CH2=CHCOO-
CH3CH=CHCH=CHCOO-
the above methylamino abamectin organic acid salt is methylamino abamectin formate, methylamino abamectin acetate, methylamino abamectin acrylate, methylamino abamectin sorbate, methylamino abamectin malate, methylamino abamectin oxalate or methylamino abamectin succinate. The organic acid salt of methylamino avermectin may be methylamino avermectin B1aOrganic acid salt, which can be methylamino abamectin B1bThe organic acid salt may be a mixture of the two.
The methylamino abamectin organic acid salt can be synthesized by the following ways: dissolving methylamino abamectin benzoate in acetone, placing the dissolved methylamino abamectin benzoate in a beaker, under the ice bath condition, slowly dropwise adding 1mol/L NaOH solution into the acetone solution under the stirring condition until the pH value of the solution is neutral, stirring for 20min, adding water, continuously stirring for 20min, ventilating in a fume hood, naturally volatilizing the acetone, carrying out column chromatography on the obtained substance, recrystallizing, carrying out freeze drying to obtain methylamino abamectin, weighing the methylamino abamectin, dissolving the methylamino abamectin in acetone, dropwise adding an organic acid acetone solution containing the organic acid until the pH value of the mixed solution is neutral, stirring for 5min, drying in the fume hood, transferring the mixed solution to a vacuum drier, and drying to obtain the methylamino abamectin organic acid salt, wherein different organic acid acetone solutions are adopted to obtain the unused methylamino abamectin organic acid salt, and the separation and purification methods used in the synthesis method are all conventional methods, for example, selective crystallization is carried out by using a proper solvent, or column separation is carried out by using silica gel and alumina, and the concentration of the obtained emamectin after purification in the reaction process is more than 95 percent.
The methylamino abamectin organic acid salt has good insecticidal effect, and is particularly suitable for killing various agricultural and forestry pests. Agricultural pests: such as cabbage moth (Plutella xylostella L.), cotton bollworm (Helicoverpa armigera), beet armyworm (Spodoptera exigua), tobacco budworm (Heliothis assitaguene), alfalfa thrips (Frankliniella acilitalis), armyworm (Leucanthia Separata Walker), Spodoptera litura (Prodenia litura Fabricius), cabbage caterpillar (Pierilis rapae Linnaeus), Epinephelus exigua (Sidemia debiva), red brown rice moth (Polia illobila Butler), cabbage caterpillar (Mam estra brasiliensis Linnaeus), alfalfa caterpillar (Heliothis virilis Htibnanogana), Spirothistle (Pyrria brueckea), tobacco budworm (Heliothis virescens), tobacco budworm (Oscilaria), tobacco budworm (Ostertagia punctata), tobacco budworm (Ostertagia japonica, etc.), cabbage caterpillar (Helicoverpa virescens), tobacco budworm (Ostertagia litura), tobacco budworm (Ostreta), tobacco budworm (apple moth, etc. Forestry pests: such as pine wood nematodes (Bursaphelenchus xylophilus), hyphantria cunea (Hypopharia cunea Drary), Trichosporon chrysis (Elerusia lcptalina), and Liriomyza sativa Blancard.
In pest control, the methylamino abamectin organic acid salt may be compounded into various kinds of conventional preparation formsUse is made, for example, of microemulsions, emulsifiable concentrates, aqueous emulsions, pastes, trunk injections, granules, powders, suspensions, aerosols and microcapsules. The preparation can be prepared by conventional method, such as microemulsion, which can be prepared by using one or more of alcohols, ketones, esters and aromatic hydrocarbons as solvent, and alkyl benzene sulfonate calcium salt, magnesium alkyl benzene sulfonate, aluminum alkyl benzene sulfonate, sodium alkyl benzene sulfonate, barium alkyl benzene sulfonate, C8-C20The anti-freezing agent is prepared by using one or more of sodium alkyl sulfate, styrene polyoxyethylene ether ammonium sulfate, benzyl diphenol polyoxyethylene ether, phenethylphenol polyoxyethylene (N15-30) ether, phenethylphenol polyoxyethylene polyoxypropylene, nonylphenol polyoxyethylene ether, alkylphenol polyoxyethylene ether methyl condensate, diphenol polyoxyethylene ether, domestic agricultural milk No. 700 and No. 300 as an emulsifier, using one or more of 3-chloro-1, 2-epoxypropane, butyl glycidyl ether, phenyl glycidyl ether, tolyl glycidyl ether, polyethylene glycol diglycidyl ether and sodium sorbate as a stabilizer, and using one or more of ethylene glycol, glycerol, propylene glycol, polyethylene glycol and sorbitol as an anti-freezing agent.
The synthesized methylamino abamectin organic acid salt may be used alone, or in combination of two or more kinds, or may be mixed with known germicide, miticide, pesticide or nematicide, herbicide and growth regulator. The active substances can be employed in the form of their formulations, such as solutions, suspensions, wettable powders, pastes, soluble powders, dusting formulations and granules, by customary methods, for example by pouring, spraying, dusting, foaming, injecting, brushing or the like. The concentration of active substance used in the treatment of the plant parts can vary within a relatively wide range, generally in the range from 1 to 0.0001% by weight, preferably from 0.5 to 0.001% by weight. When used as an injection for tree trunks, the injection dose is usually in the range of 2 to 50g/m3Preferably in the range of 5 to 20g/m3。
Compared with the prior art, the methylamino abamectin organic acid salt has the following beneficial effects:
1. compared with abamectin, the proportion of polar groups in the compound is increased, the oil-water distribution coefficient of the compound is changed, so that the modified new substance can penetrate through the plant epidermis more easily and enter the plant body, and the new substance is transported and diffused to all parts of the organism from the pesticide application position to achieve the control effect.
2. Compared with methylamino abamectin benzoate, the solubility of the compound in water is improved by dozens to hundreds of times, taking methylamino abamectin acetate as an example, the solubility of the compound in water is up to 1.242g, which is several orders of magnitude higher than abamectin (1 mu g/100mL water) and widely applied methylamino abamectin benzoate (2.4mg/100mL water); the systemic transport capacity in the plant body is greatly enhanced, and the implementation test shows that the same dose of methylamino abamectin benzoate and methylamino abamectin acetate is injected into the trunk, and the systemic quantity of the latter in the trunk is far higher than that of the former.
3. The control range of emamectin benzoate is expanded, the activity on controlling a plurality of pests is greatly increased, and experiments prove that the stomach toxicity activity of the emamectin benzoate to 3 rd larvae of diamondback moth is 4.52 times that of the emamectin benzoate, 15.73 times that of the abamectin, 335.81 times that of profenofos and 364.26 times that of cyfluthrin respectively; the stomach toxicity activity of the emamectin benzoate to the third-instar cotton bollworm is 4.29 times that of emamectin benzoate, 34.93 times that of abamectin, 205.21 times that of cypermethrin and 115.82 times that of chlorfenapyr respectively; the activity of the emamectin benzoate acrylate on the stomach toxicity of phyllotreta striolata adults is respectively 2.10 times of that of emamectin benzoate, 5.07 times of that of abamectin, 2.25 times of fipronil, 5.44 times of phoxim and 200 times of that of deltamethrin; the stomach toxicity activity of the emamectin benzoate to striped rice borers is 5.5 times of that of emamectin benzoate, 44.75 times of that of abamectin, 2580 times of fenitrothion and 5387.5 times of that of chlorpyrifos; the activity of the emamectin benzoate sorbate to the 3 rd larva of the armyworm is 1.95 times that of emamectin benzoate, 328.29 times that of abamectin, 80.66 times that of beta-cypermethrin and 8.99 times that of phoxim respectively; the emamectin succinate has high control effect on the liriomyza sativae, and the control effect after being diluted by 10000 times and sprayed is still 96.65 percent after 15 days and is far higher than that of other medicaments; the reproduction inhibition activity of the emamectin benzoate malate on the pine wood nematodes is 1.15 times that of emamectin benzoate, 2.24 times that of abamectin and 176.61 times that of cadusafos respectively.
4. Compared with the prior avermectin drugs, the avermectin drug has higher polarity, is easier to degrade in natural environment and is safer to ecological environment.
Drawings
FIG. 1 is a graph showing the control effect of 4 kinds of agents on the pine wilt disease of potted seedlings.
Detailed Description
Example 1:
accurately weighing 10g of distilled water in a 10ml graduated test tube by using an electronic analytical balance, and placing the graduated test tube in a water bath kettle at 25 ℃. Then, each compound was added thereto with shaking until it could not be dissolved. Repeat 3 times. After drying, the material was weighed and the solubility in water was calculated and the results are shown in table 1. From table 1, we can see that the solubility of emamectin benzoate organic acid salt in water is improved by about tens to hundreds times compared with emamectin benzoate.
TABLE 1 solubility of emamectin benzoate in Water
Example 2:
treating 3-year-old diamondback moth larvae by adopting a leaf dipping method under indoor conditions, and performing LC (liquid chromatography) on diamondback moths by using various medicaments at 48h50The values are shown in Table 2. As can be seen from Table 2, the emamectin benzoate has much higher activity on diamond back moths than other control medicaments, which are respectively 4.52 times of emamectin benzoate, 15.73 times of abamectin, 335.81 times of profenofos and 364.26 times of cyfluthrin, and shows extremely strong insecticidal activity.
TABLE 2 toxicity test results (48h) of agents such as methylamino avermectin acetate against 3 rd instar larvae of plutella xylostella
Example 3:
treating 3-year-old bollworm larvae by using a leaf dipping method under indoor conditions, and performing LC (liquid chromatography) of various medicaments on the bollworms in 48 hours50The values are shown in Table 3. As can be seen from Table 3, the emamectin benzoate has much higher activity to cotton bollworm than other control agents, which are respectively 4.29 times of emamectin benzoate, 34.93 times of abamectin, 205.21 times of cypermethrin and 115.82 times of chlorfenapyr, and shows extremely strong insecticidal activity.
TABLE 3 toxicity test results of emamectin benzoate and other agents on 3 rd instar cotton bollworm larvae (48h)
Example 4:
treating phyllotreta striolata adults by adopting a leaf dipping method under indoor conditions, and performing LC (liquid chromatography) of various medicaments on phyllotreta striolata adults within 48 hours50The values are shown in Table 4. As can be seen from Table 4, the activity of emamectin benzoate acrylate on phyllotreta striolata adults is much higher than that of other control agents, and the emamectin benzoate acrylate is 2.10 times that of emamectin benzoate, 5.07 times that of abamectin, 2.25 times that of fipronil and 5.44 times that of phoxim respectively, and the emamectin benzoate acrylate shows extremely strong insecticidal activity.
TABLE 4 indoor toxicity test results (48h) of Mebamido avermectin acrylate and other agents on Phyllotreta striolata adults
Example 5:
under indoor conditions, the rice sprout immersion method is adopted to treat the striped flea beetle imagoes, and LC of various medicaments to Chilo suppressalis Ant borer is carried out in 48 hours50The values are shown in Table 5. As can be seen from Table 5, the activity of emamectin benzoate to striped rice borer is much higher than that of other control medicaments, which are respectively 5.5 times of emamectin benzoate, 44.75 times of abamectin, 2580 times of fenitrothion and 5387.5 times of chlorpyrifos, and the emamectin benzoate shows extremely strong insecticidal activity.
TABLE 5 results of indoor toxicity test of drugs such as emamectin benzoate to Chilo suppressalis Ant borer (48h)
Example 6:
under indoor conditions, the leaf soaking method is adopted to treat mythimna separata larvae of 3 th instar, and LC of various medicaments for striped rice borer and Antenorhabditis borer is adopted at 48h50The values are shown in Table 6. From Table 6, it can be seenThe activity of emamectin benzoate sorbate on 3 rd larva of armyworm is much higher than that of other contrast agents, namely 1.95 times of emamectin benzoate, 328.29 times of abamectin, 80.66 times of beta-cypermethrin and 8.99 times of phoxim, and the emamectin benzoate sorbate has extremely strong insecticidal activity.
TABLE 6 indoor toxicity test results (48h) of methylamino avermectin sorbate for armyworm 3 rd instar larvae
Example 7:
under the lower concentration, the control effect of the methylamino abamectin succinate on the liriomyza sativae is far better than the control effects of emamectin benzoate, abamectin, cyromazine, dimehypo and other medicaments, and the specific implementation test results are as follows: test agents: 3% methylamino avermectin succinate microemulsion (self-prepared in laboratory) is diluted by 10000 times; diluting 3% emamectin benzoate microemulsion by 8000 times; 0.9 percent of abamectin emulsifiable solution is diluted by 2000 times; 75% cyromazine wettable powder, diluted 5000 times; diluting 18% bisultap water solution by 300 times;
selecting a test field by adopting a ridge and ridge planting mode, randomly arranging the test field in blocks, repeating the treatment for three times, and treating the test field with the specified liquid medicine of 60kg/667m3And (3) comparing with clear water, measuring 7d (about the peak time of the low-age larvae) after the peak time of the adult larvae by using a yellow plate induction method, taking 5 random points of sampling in each cell by adopting a tag mark in the first day before the drug, checking 20 leaves in each point, checking 100 leaves in total, performing population base number investigation before the drug, investigating the number of the live larvae on the leaves marked by the pre-drug investigation at 5d, 10d and 15d after the drug, calculating the corrected death rate of the larvae, and referring to a table 7.
TABLE 7 corrected mortality of larvae of liriomyza sativae, medicaments such as emamectin succinate
Example 8:
under indoor conditions, the growth and reproduction inhibiting activity of the emamectin benzoate on the pine wood nematodes is obviously higher than that of the organophosphorus pesticide and the emamectin benzoate, and the good inhibiting effect is shown. Adopting culture dish fungus bioassay method, and using methylamino abamectin malate, emamectin benzoate, abamectin and clomiphos to treat pine wood nematode IC95The values are 0.1786 mug/ml, 0.2049 mug/ml, 0.3999 mug/ml and 31.5430 mug/ml respectively, wherein the inhibiting activity of the emamectin malate is 1.15 times, 2.24 times and 176.61 times of the latter respectively. See table 8.
TABLE 8 Activity of Emamectin malate on Bursaphelenchus Xyla
Example 9:
the same dose of methylamino abamectin benzoate and methylamino abamectin organic acid salt (in this embodiment, methylamino abamectin acetate is taken as a representative) is injected into the trunk, and the systemic amount of the latter in the trunk is far higher than that of the former. As can be seen from table 9: injecting the same dose of 10g/m into the trunk3The systemic amount of the methylamino abamectin benzoate and the methylamino abamectin acetate in the trunk is far higher than that of the methylamino abamectin benzoate and the methylamino abamectin acetate. Wherein the presence of the agent is detectable at a height of 7m from the tree on day 3 after the emamectin benzoate injection. While the presence of emamectin benzoate was not detected at this position all the time. 20 days after injection, the content of the emamectin benzoate is detected to be 1.71 mu g/g at the position 4m higher than the tree, and the content of the emamectin acetate at the position can reach 20.13 mu g/g.
TABLE 9 dynamic state of delivery of two agents in Pinus massoniana
Example 10:
the comparative experiment of the prevention effect of the methylamino abamectin acetate, the clomiphos, the abamectin and the methylamino abamectin benzoate on the sick pine seedlings is carried out under the same injection dosage;
test materials: in 4 months in 2005, 4-year-old masson pine bagged seedlings with consistent sizes are selected in a nursery garden of a forest academy of sciences in Guangdong province, the height of the seedlings is 80-100cm, the diameter of the base of a trunk is 1.4-1.8cm, and each pine seedling is required to have 1-2 lateral branches. After 2 months, the plants with normal growth were taken for testing. 95% Kyoho crude (Zhejiang Yifan chemical Co., Ltd.); 95.5% of abamectin (provided by Guangxi Guilin Jiqi Co., Ltd.); 91% EB crude drug (Zhejiang Haizheng pharmaceutical Co., Ltd.); the content of the methylamino abamectin acetate technical product (synthesized by pesticide of southern China university of agriculture and key laboratory of chemical and biological education department) is not lower than 90 percent;
the test method comprises the following steps: the test adopts the treatment of trunk injection. During treatment, the seedlings are drilled at the position 5cm higher than the ground, the angle is 45 degrees with the seedlings, the aperture is 3mm, and the depth is 10 mm. Then, a large pipette tip is selected, the tip is cut off, and the tip is inserted into the hole. Then the medicine is injected into the gun hole, and the medicine hole is sealed by adhesive plaster. The nematode inoculation adopts a lopping casing method. Selecting one lateral branch of the in-vitro pine branch, cutting off the treetop at a position about 5cm away from the main branch to enable the cross section to be upward, winding a little absorbent cotton at the base part of the cross section, sleeving a latex tube with the length of about 8cm, fastening the base part of the latex tube by using a string, and injecting nematode suspension liquid from a gate, wherein the inoculation amount is 10000 per branch. The nozzle was then plugged with wet degreased cotton to maintain the humidity in the latex tube for nematode penetration. Each agent is provided with 1, 5, 10 and 20g/m34 concentrations, 10 shoots were selected for each concentration. In addition, 10 seedlings were selected to inject 1ml of acetone without inoculatingThe worms were used as control I, 10 seedlings were inoculated with 1ml acetone as control II. And (5) inoculating 15 days after the injection. The disease grading standard adopts the method of Xufuyuan et al, and the needle leaves are classified into 5 grades according to the degrees of chlorosis, withered and yellow and reddening: level 0 (representative value 0), normal; grade I (representative value 1), chlorosis, part of the needles (below 1/4) turned yellow; in class II (typical value 2), 2/4-3/4 needles turned yellow, and needles below 1/4 turned red; grade III (typical value 3), the color of needle leaves turns red from about 1/4 to 3/4; grade IV (representative value 4), above 3/4, turns red and dies. And calculating the infection index of the test seedlings and the prevention and treatment effect of the medicament after 60 days of inoculation by taking the test seedlings as a standard. And (3) shearing quantitative test seedling main stems for plants with the disease progression of more than I, carrying out nematode separation by a Beemann funnel method in a laboratory, and carrying out microscope examination and counting under a dissecting mirror. Wherein,
disease index ═ Σ (damage degree representative value:numberof disease strains at this stage)/(number of total strains at the highest stage representative value)
The control effect is [ (control susceptibility index-treatment susceptibility index)/control susceptibility index ]. 100%
The volume calculation formula of the sapling is as follows:
V(m3)=1/3×π〔d(m)/2〕2×h(m)×2,
d is the diameter of the base of the tree trunk, h is the height of the seedling
The preparation of the medicament comprises: 1g of the medicament is weighed and dissolved in 10ml of acetone solution, and the injection dosage is calculated according to the test concentration and the volume of the sapling.
And (3) test results: the method comprises the steps of treating pine seedlings by adopting a medicament injection method and then inoculating nematodes, wherein the control effect of 4 medicaments such as methylamino abamectin acetate and the like on pine wood nematode diseases under different concentrations is shown in figure 1 after 2 months, in order to reflect the systemic dispersion and dispersion of the medicaments in the pine seedlings and the control effect of the nematodes, no emulsifier is added in the preparation process of the experimental medicament, and as is obvious from figure 1, when the medicament injection dosage is 1g/m3In the process, 4 medicaments have no control effect on the pine wood nematodes, and the content of the methylamino abamectin acetate is the highest and is only 7.5 percent. Prevention of pine wilt disease by 4 medicaments with increasing injection dosageThe effect is obviously improved. When the injection dosage is 20g/m3In the process, the control effect of the methylamino avermectin acetate reaches 95 percent and is obviously higher than that of AVM (45 percent), EB (60 percent) and cadusafos (77.5 percent). The methylamino abamectin acetate is one kind of systemic medicine with water solubility up to 2150mg/L and is transported to effective concentration in pine seedling after being injected into tree to reach preventing and treating effect. Although the growth and reproduction inhibiting effect of the AVM and the EB on the pine wood nematodes under indoor conditions is far higher than that of clomiphos, the control effect on the pine wood nematode disease of the masson pine is lower than that of the other pine wood nematode disease under the same concentration. This is because: the solubility of AVM and EB in water is 0.01mg/L and 24mg/L respectively, when injected into the pine body, it is difficult to dredge upwards in a short time and reach effective dose in the tree body, and the clorophos is a two-way dredging systemic medicament, the solubility in water is 700mg/L, and after injected, it can be quickly transported to effective concentration in the pine body to obtain the effect of prevention and cure. Therefore, under the same injection dosage, the prevention effect of the emamectin benzoate on the sick pine seedlings is higher than that of the clomiphos, the abamectin and the emamectin benzoate.
Example 11: composition of 0.3% methylamino abamectin acetate microemulsion and preparation method thereof
The main agent of the embodiment comprises the following effective components in percentage by weight (%): methylamino abamectin acetate 3;
the auxiliary agent comprises the following components in percentage by weight: solvent: 10 parts of methanol; emulsifier: ethylene oxide 11, calcium dodecylbenzenesulfonate 8: 78, water;
the raw materials with the weight ratio are mixed and then are prepared into the microemulsion by a microemulsion processing method.
Example 12: preparation of methylamino abamectin organic acid salt
Preparing methylamino abamectin acetate: dissolving 19g of 91% methylamino abamectin benzoate in 200ml of acetone, placing the mixture in a 1000ml big beaker, slowly and dropwise adding 20ml of 1mol/L NaOH into an acetone solution under the stirring condition under the ice-dissolving condition until phenolphthalein turns red, stirring for 20min, adding 200ml of water, continuing stirring for 20min, ventilating in a ventilation cabinet, wherein the door is slightly higher than the mouth of the beaker, and naturally volatilizing the acetone. And carrying out column chromatography, recrystallization and freeze drying on the obtained substance to obtain the compound I. Weighing 8.80g of the compound I, dissolving the compound I by using 100ml of acetone, dropwise adding 2ml of acetic acid acetone solution containing 0.6g of glacial acetic acid into the solution, stirring for 5min, drying in a fume hood, and then transferring to a vacuum drier for drying to obtain the product of the methylamino abamectin acetate with the concentration of more than 90%. By adopting the same preparation method, acetic acid is replaced by formic acid, acrylic acid, sorbic acid, malic acid, oxalic acid and succinic acid to obtain methylamino abamectin formate, methylamino abamectin acrylate, methylamino abamectin sorbate, methylamino abamectin malate, methylamino abamectin oxalate and methylamino abamectin succinate.
Claims (3)
1. The structure of the methylamino abamectin organic acid salt is as the formula (I):
wherein:
x represents CH3Or CH2CH3
R-is acid radical anion of formic acid, acetic acid, acrylic acid, sorbic acid, malic acid, oxalic acid or succinic acid, and is shown as follows:
2. the preparation method of the emamectin benzoate as claimed in claim 1, which is characterized by comprising the following steps: dissolving methylamino abamectin benzoate in acetone, and slowly and dropwise adding a NaOH solution under an ice bath condition until the pH value of the solution is neutral; adding water after full stirring, continuously stirring, ventilating in a fume hood, and naturally volatilizing acetone; performing column chromatography on the obtained substance, recrystallizing, and freeze-drying to obtain methylamino abamectin; dissolving methylamino abamectin in acetone, adding organic acid acetone solution containing organic acid drop by drop until the pH value of the mixed solution is neutral, stirring, drying in a fume hood, transferring to a vacuum drier, and drying to obtain the methylamino abamectin organic acid salt.
3. The use of the emamectin benzoate organic acid salt of claim 1 in the preparation of a pesticide for pine wood nematodes.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200610123017A CN1948328B (en) | 2006-10-26 | 2006-10-26 | Methyl amine abamectin acylate and its preparation method and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200610123017A CN1948328B (en) | 2006-10-26 | 2006-10-26 | Methyl amine abamectin acylate and its preparation method and application |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1948328A CN1948328A (en) | 2007-04-18 |
CN1948328B true CN1948328B (en) | 2010-05-12 |
Family
ID=38017966
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200610123017A Expired - Fee Related CN1948328B (en) | 2006-10-26 | 2006-10-26 | Methyl amine abamectin acylate and its preparation method and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1948328B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103168783A (en) * | 2011-12-22 | 2013-06-26 | 成都绿金高新技术股份有限公司 | Azadirachtin emulsion composition and preparation method of azadirachtin emulsion composition |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104876990B (en) * | 2015-06-02 | 2017-11-14 | 宁夏泰瑞制药股份有限公司 | A kind of method for purifying emamectin benzoate crude product |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1649888A (en) * | 2002-05-07 | 2005-08-03 | 辛根塔参与股份公司 | 4'-Deoxy-4'-(s)-amido avermectin derivatives |
-
2006
- 2006-10-26 CN CN200610123017A patent/CN1948328B/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1649888A (en) * | 2002-05-07 | 2005-08-03 | 辛根塔参与股份公司 | 4'-Deoxy-4'-(s)-amido avermectin derivatives |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103168783A (en) * | 2011-12-22 | 2013-06-26 | 成都绿金高新技术股份有限公司 | Azadirachtin emulsion composition and preparation method of azadirachtin emulsion composition |
CN103168783B (en) * | 2011-12-22 | 2014-09-03 | 成都绿金高新技术股份有限公司 | Azadirachtin emulsion composition and preparation method of azadirachtin emulsion composition |
Also Published As
Publication number | Publication date |
---|---|
CN1948328A (en) | 2007-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Doccola et al. | Tree injection as an alternative method of insecticide application | |
CN102771510B (en) | Insecticidal composition containing fosthiazate | |
CN106538597B (en) | A kind of nematicidal composition containing fosthiazate | |
CN101352169B (en) | Pesticide composition based on ivermectin | |
CN102578132B (en) | Pesticide composition containing spinetoram and neonicotinoid insecticide | |
CN103734171A (en) | Pesticide composition containing imidacloprid | |
CN114431256A (en) | Compound composition containing pyrethrin and beauveria bassiana and application thereof | |
CN101856027B (en) | Pesticide preparation for controlling diamond back moth and other vegetable insect pests | |
CN104663693B (en) | A kind of composition of containing pyriminostrobin and its application | |
WO2014068303A1 (en) | Method of monitoring and/or controlling thysanoptera | |
CN101836643B (en) | Pesticide preparation for controlling vegetable pests of diamondback moth and the like | |
CN104522054A (en) | Biological source synergistic compound insecticide, preparation method and application thereof | |
CN101803605B (en) | Insecticidal composition of butene-fipronil and spinosad | |
CN1948328B (en) | Methyl amine abamectin acylate and its preparation method and application | |
CN105410013A (en) | Insecticide-pesticide mixture preparation | |
Huang et al. | Evaluation of the effectiveness of insecticide trunk injections for control of Latoia lepida (Cramer) in the sweet olive tree Osmanthus fragrans | |
CN106561656B (en) | A kind of Pesticidal combination containing Celastrus angulatus and multiple killing teichomycin | |
CN104996458A (en) | Pesticide composition and applications thereof | |
CN102524292A (en) | Special effect formula for controlling whitefly | |
CN103719115B (en) | A kind of Pesticidal combination | |
CN104522006B (en) | A kind of preventing and treating Lepidoptera and homoptera pest compositions | |
CN100399896C (en) | Application of alpha-trithiophene in control of pine wood nematode disease | |
CN103734168B (en) | Insecticidal pesticide formulation containing biopesticide-rotenone | |
CN103380779B (en) | A kind of Pesticidal combination containing cycolxylidin and biological source insecticide | |
CN107980789A (en) | A kind of Pesticidal combination containing fourth chlorantraniliprole and its application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100512 Termination date: 20211026 |
|
CF01 | Termination of patent right due to non-payment of annual fee |